Cochrane Abstracts
Short acting beta2‐agonists for recurrent wheeze in children under two years of age
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Short Acting Beta2‐agonists for Recurrent Wheeze in Children Under Two Years of Age." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438578/all/Short_acting_beta2‐agonists_for_recurrent_wheeze_in_children_under_two_years_of_age.
Short acting beta2‐agonists for recurrent wheeze in children under two years of age. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438578/all/Short_acting_beta2‐agonists_for_recurrent_wheeze_in_children_under_two_years_of_age. Accessed March 26, 2025.
Short acting beta2‐agonists for recurrent wheeze in children under two years of age. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438578/all/Short_acting_beta2‐agonists_for_recurrent_wheeze_in_children_under_two_years_of_age
Short Acting Beta2‐agonists for Recurrent Wheeze in Children Under Two Years of Age [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438578/all/Short_acting_beta2‐agonists_for_recurrent_wheeze_in_children_under_two_years_of_age.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Short acting beta2‐agonists for recurrent wheeze in children under two years of age
ID - 438578
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438578/all/Short_acting_beta2‐agonists_for_recurrent_wheeze_in_children_under_two_years_of_age
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
